Abstract Background and objectives: Hepatitis-causing viral agents other than those designated A to E are being reported. Their epidemiology, modes of transmission, and infectivity are not yet clear, although they may be transmitted by transfusion. Materials and methods: Thirty five patients underwent open-heart surgery, receiving an average of 10.2±10.8 (range 1 to 35) units of blood. The patients were investigated postoperatively for the RNA of the putative non-Ato-E hepatitis virus designated as GB virus C (GBV-C). Results: Four patients (12%) acquired GBV-C RNA in the serum within 2 to 4 weeks after the operation. GBV-C RNA was detected in at least one of the blood units received by three patients, all of whose units were available for testing, with a sequence in the nonstructural 3 region identical to that from the corresponding patient. Three patients developed elevated alanine aminotransferase levels which persisted for two weeks or longer in two of them. Conclusions: GBV-C is transmissible by transfusion and can induce elevated transaminase levels.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.